Celecoxib Oral Suspension (Anhydrous)
Celecoxib is a compounded formulation containing Celecoxib, prepared by Mixlab for veterinary use. Available by prescription.
How to Give Anhydrous Oral Suspension
Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:
- Shake well each time to mix the medication (5-10 seconds).
- Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
- Hold your pet steady: a towel or helper can assist with squirmy pets.
- Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
- Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
- Praise your pet and offer a treat or water (unless advised against feeding right after).
- Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
- Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Veterinarians most commonly consider celecoxib for patients presented with osteoarthritis or other chronic musculoskeletal conditions where long-term mobility support is a clinical priority. It is also frequently a point of discussion for canine patients requiring management of the physiological response to surgical procedures. By targeting specific biochemical pathways associated with tissue irritation, your veterinarian can manage the pet’s physical state while aiming to minimize interference with normal homeostatic processes.
At a pharmacological level, celecoxib acts as a highly selective inhibitor of the cyclooxygenase-2 (COX-2) enzyme. In the body, the COX-2 enzyme is responsible for the synthesis of prostaglandins, which serve as the primary chemical mediators of inflammation, redness and localized swelling. Celecoxib is notable in its relative sparing of the cyclooxygenase-1 (COX-1) enzyme at therapeutic doses. This distinction is significant because the COX-1 enzyme is associated with maintaining the protective lining of the stomach and supporting renal blood flow. By selectively binding to the COX-2 site, the medication provides a targeted approach to managing inflammatory signals. Your veterinarian will determine whether celecoxib is appropriate for your pet based on physical examination findings and baseline diagnostic testing, such as liver and kidney panels.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects following the administration of celecoxib include localized digestive changes such as vomiting, diarrhea or a temporary decrease in appetite. Some owners may also observe behavioral shifts including lethargy or changes in water consumption. Because all NSAIDs influence renal and hepatic pathways, your veterinarian will monitor for signs of liver or kidney sensitivity through periodic blood work, especially during sustained use. Owners should watch for signs of jaundice (yellowing of the eyes or gums) or dark, tarry stools and contact their veterinarian promptly if these occur.
This medication is typically used with extra caution or avoided in patients with known pre-existing renal or hepatic impairment, bleeding disorders or active gastroduodenal ulceration. It is also carefully evaluated in breeding, pregnant or lactating dogs, as safety in these specific categories has not been fully established. Significant interactions can occur if celecoxib is administered concurrently with other prescriptions like corticosteroids or other NSAIDs, as this combination can increase the risk of gastrointestinal irritation. Your veterinarian is the right person to provide guidance on the necessary monitoring frequency and the proper administration schedule to ensure the management approach remains suitable for your pet's individual needs.
Yes. Celecoxib is a prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all veterinarian-client-patient relationships before any medication is prepared or shipped.
Yes. While celecoxib is available in various commercial capsule formats intended for human use, Mixlab specializes in compounding the active ingredient into customized strengths and flavored dosage forms—such as flavored oral liquids or smaller capsules—to suit the specific needs of dogs. The decision between a commercial and compounded product rests with the prescribing veterinarian.
While both celecoxib and Rimadyl (carprofen) belong to the NSAID family and are utilized to manage inflammation, they belong to different chemical sub-classes and have slightly different pharmacological profiles. Your veterinarian will select the specific medication they believe is most appropriate based on your pet's health history and the clinical context.
The most important observational signs to monitor include a sudden loss of appetite, vomiting or a change in stool color to a dark or black appearance. If you observe any of these changes or if your pet appears unusually tired, you should contact your veterinarian immediately for a clinical assessment and potential blood work.
